GHENT UNIVERSITY Patent applications |
Patent application number | Title | Published |
20130035494 | Process for Preparation of Ruthenium-Based Carbene Catalysts with Chelating Alkylidene Ligands - The invention relates to a method for preparation of ruthenium-based carbene catalysts with chelating alkylidene ligands (so-called “Hoveyda-type catalysts”) in a cross metathesis reaction by reacting a ruthenium-alkylidene complex with an olefin derivate in the presence of a polymer-supported cation-exchange resin (PSR) acting as a ligand (i.e. phosphine or amine) scavenger. Preferably, penta-coordinated ruthenium benzylidene or indenylidene carbene complexes are employed. The polymer-supported cation-exchange resin (PSR) may be an acidic resin (comprising sulfonic acid or carboxylic groups) or a resin containing carboxylic acid chloride (—COCl) groups or sulfonyl chloride (—SO | 02-07-2013 |
20120076378 | METHOD AND ASSEMBLY FOR CORRECTING A RELAXATION MAP FOR MEDICAL IMAGING APPLICATIONS - A method for correcting a relaxation map of an object scanned with a magnetic resonance imaging modality the object having a plurality of structure and/or tissue types. The method includes deriving a first relaxation map of a scanned object from at least two three-dimensional scans of the object acquired using a sequence of ultrashort echo time pulses adapted for distinguishing between the various types of a plurality of structure and/or tissue types of the object. Information is obtained on the type of structure and/or tissue type present in voxels in the first relaxation map and binarizing the obtained information. A corrected relaxation map is generated by combining the binarized information with the first relaxation map. | 03-29-2012 |
20110306574 | INHIBITORS OF F18+ E COLI BINDING - The present invention relates to blood group A/B/H determinant on Type 1 Core glycosphingolipids chains as recognition point for the FedF protein of F18-fimbriated Enterotoxigenic and verotoxinogenic | 12-15-2011 |
20110263948 | SCORING SYSTEM TO MONITOR NATURAL OR DRUG-MODIFIED DISEASE PROGRESSION IN "EROSIVE OSTEOARTHRITIS" OF THE INTERPHALANGEAL FINGER JOINTS - The present invention provides a scoring system to monitor natural or drug-modified disease progression in erosive inter-phalangeal finger joint osteoarthrits and the use of said scoring system to identify and value drugs with anticatabolic and/or repair promoting potential. | 10-27-2011 |
20110142916 | Adjuvants for Use in Vaccination - A compound of formula (I) for use as an adjuvant in vaccination; wherein R is an optionally-substituted alkyl, alkenyl, alkynyl, aryl, arylalkyl or alkylaryl moiety having from 1 to 50 carbon atoms; R | 06-16-2011 |
20100158947 | PERMISSIVE CELLS AND USES THEREOF - The invention relates generally to the field of virology. More particularly, the present invention relates to methods for determining the permissiveness of a cell for a virus that is a member of the family Arteriviridae or Coronaviridae or Asfarviridae, in particular for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). The invention further provides methods and compositions related to the generation of host cells permissive for a virus that is a member of the family Arteriviridae or Coronaviridae or Asfarviridae, in particular for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). Methods of using said cells thus identified or thus generated, in preparing a culture of a virus that is a member of the family Arteriviridae or Coronaviridae or Asfarviridae, as well as the use of said virus for the purpose of vaccine production or diagnosis, are also provide by the present invention. | 06-24-2010 |
20090111782 | COMPOSITION AND METHODS RELATING TO GLUCOCORTICOID RECEPTOR-ALPHA AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS - Methods of treating a glucocorticoid-responsive condition in a subject are provided according to embodiments of the present invention which include administering, in combination, a glucocorticoid receptor agonist and a PPAR agonist in therapeutically effective amounts. It is an aspect of the present invention that the amount of the glucocorticoid receptor agonist used in a method of treating a glucocorticoid-responsive condition is less than an amount of the glucocorticoid receptor agonist necessary to achieve a therapeutic effect if administered in the absence of the PPAR agonist. | 04-30-2009 |
20080319461 | SUTURELESS VESSEL ANASTOMOSIS METHOD AND APPARATUS - A method for performing end-to-end vessel anastomosis includes providing a vessel support including a vessel receiving portion and a handle portion extending therefrom. The vessel receiving portion is an annulus. The vessel receiving portion is positioned around the end of a first vessel and the end of the first vessel is everted about the outer diameter of the vessel receiving portion such that the inner surface of the vessel is directed outwardly. The end of the second vessel is positioned over the everted end of the first vessel such that the inner surface of the second vessel is disposed against the inner surface of the first vessel. A surgical adhesive is provided and is used to adhere the ends of the vessels together without requiring the application of heat or radiant energy. The handle portion of the vessel support may be removed. | 12-25-2008 |